HomePharma

Pharma

Takeda Launches Narcolepsy Drug ORZEYFUL in Japan and China, U.S. Launch Planned

Life Sciences Times - October 15, 2026

Pharma

Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment

Life Sciences Times - October 14, 2026

Pharma

Calluna Pharma Completes Dosing in Phase 2 Lung Fibrosis Trial, Expects Results in Early 2027

Life Sciences Times - October 13, 2026

Pharma

Alkermes to Present New Narcolepsy and Sleep Disorder Treatment Data at Sleep Europe 2026

Life Sciences Times - October 13, 2026

Pharma

Scholar Rock Resubmits European Application for Spinal Muscular Atrophy Treatment

Life Sciences Times - October 8, 2026

Pharma

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

Life Sciences Times - February 22, 2021 0

Pharma

Xlife Sciences AG: Antiviral drug candidate for SARS-CoV-2

Life Sciences Times - February 17, 2021 0

Pharma

M6P Therapeutics Presents Promising Preclinical Data in Lysosomal Storage Disorders at the 17th Annual WORLDSymposium™ 2021

Life Sciences Times - February 11, 2021 0

Pharma

Drug Topics® Announces Partnership with inPharmacyJobs

Life Sciences Times - February 11, 2021 0

Pharma

New Zealand approves 1st Covid-19 vaccine

Life Sciences Times - February 10, 2021 0

Pharma

Global Anti-inflammatory Drugs Market to Surpass US$ 142,223.4 Million by 2027, Says Coherent Market Insights

Life Sciences Times - February 8, 2021 0

Pharma

COVAXX’s COVID-19 Vaccine, UB-612, Induced Neutralizing Antibodies in 100% of Participants During Phase 1 Clinical Trial

Life Sciences Times - February 8, 2021 0

Pharma

AstraZeneca’s anti-diabetic drug gets nod for kidney disease in India

Life Sciences Times - February 8, 2021 0

Pharma

Reverie Labs Raises $25 Million Series A Round

Life Sciences Times - February 5, 2021 0

Pharma

MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

Life Sciences Times - February 4, 2021 0

Pharma

AstraZeneca says vaccine 76% effective for 90 days after single dose

Life Sciences Times - February 3, 2021 0

Pharma

Daiichi Sankyo Initiates Clinical Development of Sixth DXd ADC DS-6000 with Sarah Cannon Research Institute

Life Sciences Times - February 2, 2021 0

1...969798...101 Page 97 of 101

Perceptive Discovery Expands Radiopharmaceutical Research Capabilities in Massachusetts and UK

October 16, 2026

Boston-Based Clasp Launches Healthcare Job Marketplace Offering Student Loan Repayment Benefits

October 16, 2026

Ironwood Pharmaceuticals Names Tammi Gaskins CEO as Tom McCourt Announces Retirement

October 16, 2026

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

October 16, 2026

Pharma

Takeda Launches Narcolepsy Drug ORZEYFUL in Japan and China, U.S. Launch Planned

Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment

Calluna Pharma Completes Dosing in Phase 2 Lung Fibrosis Trial, Expects Results in Early 2027

Alkermes to Present New Narcolepsy and Sleep Disorder Treatment Data at Sleep Europe 2026

Scholar Rock Resubmits European Application for Spinal Muscular Atrophy Treatment

Most Read

Perceptive Discovery Expands Radiopharmaceutical Research Capabilities in Massachusetts and UK

Boston-Based Clasp Launches Healthcare Job Marketplace Offering Student Loan Repayment Benefits

Ironwood Pharmaceuticals Names Tammi Gaskins CEO as Tom McCourt Announces Retirement

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

EDITOR PICKS

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

Akamis Bio Completes Enrollment in Phase 1b Rectal Cancer Treatment Study

Mursla Bio Publishes Study Validating Tissue-Specific Liquid Biopsy Technology

THIS WEEK'S STORIES

Nimbus Therapeutics Appoints Three Senior Leaders to Advance Drug Discovery Programs

Quantori Recognized in Everest Group’s 2026 Pharmaceutical R&D IT Services Assessment

Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment

POPULAR CATEGORY

ABOUT US

FOLLOW US